Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (241-250 of 479) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupSumit Gupta, Cindy Wang, Elizabeth A Raetz, et al.
Cancer Research|March 14, 2019
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic LeukemiaErnesto Diaz-Flores, Evan Q Comeaux, Kailyn L Kim, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
British Journal of Haematology|July 20, 2016
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemiaRachel E Rau, Andrew J Carroll, Nyla A Heerema, et al.
Blood|April 27, 2013
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemiaShilpa Gandre-Babbe, Prasuna Paluru, Chiaka Aribeana, et al.
Haematologica|January 30, 2025
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trialMargot S F Roeten, Johan Van Meerloo, Suzanne N Van Dijk, et al.
Cancer|November 8, 2017
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trialDaniel J Zheng, Xiaomin Lu, Reuven J Schore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology GroupKristina K Hardy, Leanne Embry, John A Kairalla, et al.
Haematologica|April 21, 2019
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology GroupElizabeth A Raetz, Mignon L Loh, Meenakshi Devidas, et al.
Cancer Cell|June 28, 2002
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaAdolfo A Ferrando, Donna S Neuberg, Jane Staunton, et al.
Pageof 48

Showing results (241-250 of 479) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupSumit Gupta, Cindy Wang, Elizabeth A Raetz, et al.
Cancer Research|March 14, 2019
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic LeukemiaErnesto Diaz-Flores, Evan Q Comeaux, Kailyn L Kim, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
British Journal of Haematology|July 20, 2016
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemiaRachel E Rau, Andrew J Carroll, Nyla A Heerema, et al.
Blood|April 27, 2013
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemiaShilpa Gandre-Babbe, Prasuna Paluru, Chiaka Aribeana, et al.
Haematologica|January 30, 2025
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trialMargot S F Roeten, Johan Van Meerloo, Suzanne N Van Dijk, et al.
Cancer|November 8, 2017
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trialDaniel J Zheng, Xiaomin Lu, Reuven J Schore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology GroupKristina K Hardy, Leanne Embry, John A Kairalla, et al.
Haematologica|April 21, 2019
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology GroupElizabeth A Raetz, Mignon L Loh, Meenakshi Devidas, et al.
Cancer Cell|June 28, 2002
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaAdolfo A Ferrando, Donna S Neuberg, Jane Staunton, et al.
Pageof 48